Endoscopy Impact Factor

This journal's metric profile is unusual in a useful way. The two-year JIF is higher than the five-year JIF. That usually means the journal gets cited quickly because papers are operationally useful. In Endoscopy's case, that makes sense. Strong procedural studies, techniques, and practice-relevant reviews can become highly cited soon after publication because the field uses them immediately.

The JIF without self-cites is 10.6, which is still very high. That means Endoscopy is not leaning on internal citation loops to sustain the headline figure.

The JCI of 3.23 is especially strong. Normalized against field baseline, that says the journal substantially outperforms the average title in its category.

Some authors see 12.8 and assume the journal behaves like a broad flagship GI venue. It does not.

Endoscopy is a top journal, but it is a specialty procedural journal. That changes the editorial question. The journal is not asking only whether the paper is clinically respectable. It is asking whether the work gives endoscopists a real procedural or diagnostic advance worth their limited reading time.

That is why excellent GI papers still miss here. If the endoscopy layer is thin, editors usually know quickly.

The current JCR row is the hard benchmark on this page. For a longer directional read, the table below uses the open Scopus-based impact score series as a proxy for how the journal's recent-citation strength has moved across the last decade.

The open trend is down from 1.97 in 2023 to 1.64 in 2024, and down from 2.09 in 2021. That is worth reading carefully. It does not contradict the strong 12.8 JCR figure. It suggests the journal's citation profile depends heavily on short-window procedural utility, guidelines, and technique-led behavior, which can move around faster than broader clinical journals do.

In other words, Endoscopy still reads like a top specialty journal, but the open trend reminds you that this is a procedural field. Citation velocity can move with technique cycles faster than older general-medicine journals do.

In our pre-submission review work on manuscripts targeting Endoscopy, the fastest misses are usually visible on page one. Editors explicitly screen for practical endoscopic consequence. If the intervention or diagnostic lesson is weak, the manuscript reads like general GI work trying to borrow procedural language.

SciRev community reports line up with that pattern. Authors tend to move quickly to a first decision at this journal, which means the initial fit question matters more than polishing around the margins.

Three patterns show up repeatedly in manuscripts that struggle with this journal.

The series is too small for the claim. Endoscopy is unusually unforgiving of underpowered retrospective claims about technique superiority or safety when the sample size cannot plausibly support them.

The study is GI, but not really Endoscopy. Many papers are solid gastroenterology manuscripts with only partial procedural relevance. That is not enough for this venue.

The case report is competent but teaches nothing new. Endoscopy will take cases, but not routine ones. The case needs a distinct procedural, diagnostic, or management lesson.

If that sounds familiar, an Endoscopy submission readiness check usually surfaces the problem faster than another round of line editing.

It does not measure:

• whether the intervention changes real endoscopic decision-making
• whether the series is adequately powered for the endpoint claimed
• whether the technique is truly distinct from what the field already knows
• whether Gut, Gastrointestinal Endoscopy, or a broader GI journal is the cleaner target

That is the actual submission decision.